ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
Sergott, Robert C., Bennett, Jeffrey L., Rieckmann, Peter, Montalban, Xavier, Mikol, Daniel, Freudensprung, Ulrich, Plitz, Thomas, van Beek, JohanVolume:
351
Language:
english
Journal:
Journal of the Neurological Sciences
DOI:
10.1016/j.jns.2015.02.019
Date:
April, 2015
File:
PDF, 241 KB
english, 2015